Last reviewed · How we verify
Budesonide, Formoterol Fumarate Dihydrate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Budesonide, Formoterol Fumarate Dihydrate (Budesonide, Formoterol Fumarate Dihydrate) — Teva Pharma GmbH.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Budesonide, Formoterol Fumarate Dihydrate TARGET | Budesonide, Formoterol Fumarate Dihydrate | Teva Pharma GmbH | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Budesonide, Formoterol Fumarate Dihydrate CI watch — RSS
- Budesonide, Formoterol Fumarate Dihydrate CI watch — Atom
- Budesonide, Formoterol Fumarate Dihydrate CI watch — JSON
- Budesonide, Formoterol Fumarate Dihydrate alone — RSS
Cite this brief
Drug Landscape (2026). Budesonide, Formoterol Fumarate Dihydrate — Competitive Intelligence Brief. https://druglandscape.com/ci/budesonide-formoterol-fumarate-dihydrate. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab